Blue Jet Healthcare schedules Q2 and H1 FY26 earnings call

Blue Jet Healthcare Limited has scheduled an earnings call for Tuesday, November 4, 2025, at 5:00 PM IST. The call will focus on the company's unaudited standalone financial results for the quarter and half-year ended September 30, 2025. This event is being held in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Participants can join the conference call via universal access numbers +91 22 6280 1107 or +91 22 7115 8008. International toll-free options are available for the USA (18667462133), UK (08081011573), Singapore (8001012045), and Hong Kong (800964448), with a DiamondPass™ link also provided for direct access. Attendees are requested to dial in 10 minutes prior to the scheduled start time.

Key management representatives, including managing director shiven arora, chief operating officer V.K. Singh, chief financial officer ganesh karuppannan, and deputy chief financial officer sanjay sinha, will be present to address participants. Blue Jet Healthcare is a global, science-led pharmaceutical company specializing in contract development and manufacturing of pharmaceutical intermediates and APIs.